PEG-PBAE Gene Vectors for Biological Barrier Penetration

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current gene delivery vectors face challenges such as low packaging capacity, high production costs, risk of mutagenesis, and immune responses, along with instability and inability to penetrate biological barriers like airway mucus and brain tissue, limiting their effectiveness in vivo.

Innovation Solution

Development of compact, colloidally stable poly(β-amino ester) (PBAE)-based gene vectors with a dense surface coverage of hydrophilic, neutrally charged PEG (PEG-PBAE) that maintain stability and facilitate penetration through biological barriers, enabling high-level transgene expression.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If cationic polymer-based gene vectors are used to achieve efficient gene transfer and DNA compaction, then transfection efficiency is improved, but colloidal stability under physiological conditions deteriorates

Engineering Contradiction:

Improvetransfection efficiencyVSAvoidcolloidal stability

Core Design Contradiction:

ProductivityVSStability of the object's composition

Solution Approach 1:

The patent combines cationic polymer (for DNA compaction and transfection efficiency) with neutral hydrophilic polymer PEG (for colloidal stability and barrier penetration). This composite structure allows the vector to maintain both high transfection efficiency and stability in physiological conditions, resolving the contradiction between the two properties.

Inventive Principle:

Principle #40Composite materials

2Productivity

If highly cationic polymer vectors are used to achieve stable DNA compaction and protection from enzymatic degradation, then gene delivery efficiency is improved, but cytotoxicity increases

Engineering Contradiction:

Improvegene delivery efficiencyVSAvoidcytotoxicity

Core Design Contradiction:

ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent applies local quality by concentrating the cationic character only in the core region where DNA compaction occurs, while the outer surface is covered with neutral PEG. This spatial differentiation allows efficient DNA binding and protection without exposing the full positive charge to cellular components, thereby reducing cytotoxicity while maintaining gene delivery efficiency.

Inventive Principle:

Principle #3Local quality

3Productivity

If conventional gene vectors are used for gene delivery, then transgene expression is achieved, but ability to penetrate biological barriers such as airway mucus and brain tissue deteriorates

Engineering Contradiction:

Improvetransgene expressionVSAvoidpenetration capability

Core Design Contradiction:

ProductivityVSEase of operation

Solution Approach 1:

The patent introduces PEG as an intermediary layer between the cationic polymer core and the biological environment. This PEG coating acts as a mediator that prevents interactions with negatively charged components of biological barriers (mucus, extracellular matrix), enabling the vector to penetrate these barriers while maintaining its transgene delivery function.

Inventive Principle:

Principle #24Intermediary (Mediator)

4Productivity

If viral gene vectors are used to achieve efficient gene transfer, then transfection efficiency is improved, but production cost and technical difficulty increase

Engineering Contradiction:

Improvetransfection efficiencyVSAvoidproduction scalability

Core Design Contradiction:

ProductivityVSEase of manufacture

Solution Approach 1:

The patent employs synthetic polymer-based vectors that can be produced through simple chemical synthesis rather than complex biological manufacturing processes. These non-viral vectors eliminate the need for cell culture, purification, and quality control steps required for viral vectors, making them cheaper and easier to manufacture at scale while maintaining effective transfection.

Inventive Principle:

Principle #27Cheap short-living objects (Disposable)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

PEG-PBAE vectors demonstrate enhanced stability and penetration capabilities, achieving widespread distribution and prolonged transgene expression in vivo, particularly in the respiratory and central nervous systems, with improved safety profiles and efficacy compared to conventional vectors.

Implementation Method 1

the number of protonable amines provides increased buffering capacity that facilitates endosome escape via the 'proton sponge effect', leading to efficient transfection

Methodology Applied

Scientific EffectProton sponge effect:

Implementation Method 2

PEGylation of the cationic polymer core provides a stealth effect that reduces protein adsorption and immune recognition

Methodology Applied

Scientific EffectStealth effect:

Data Source

PatentUS11007279B2Highly stable biodegradable gene vector platforms for overcoming biological barriers

Publication Date: 2021.05.18 JOHNS HOPKINS UNIVERSITY

AI summary

A major challenge in non-viral gene delivery remains finding a safe and effective delivery system. Colloidally stable non-viral gene vector delivery systems capable of overcoming various biological barriers, are disclosed. The gene vectors are biodegradable, non-toxic and highly tailorable for use in specific applications. The vectors include a mixture of biodegradable copolymers, such as PBAE, and biodegradable polymers conjugated with hydrophilic, neutrally charged polymer, such as PEG. The gene vectors demonstrate broad vector distribution and high transgene delivery in vivo, providing an efficient non-viral gene delivery system for localized therapeutic gene transfer. Methods of using the vectors to overcome biological barriers including mucus gel and extracellular matrix are provided. Methods of formulating the vectors are also provided.